Oppenheimer analyst Leland Gershell downgrades PLx Pharma (NASDAQ:PLXP) from Outperform to Perform.
Analyst Ratings for Alaska Air Gr
Within the last quarter, Alaska Air Gr (NYSE:ALK) has observed the following analyst ratings:
Oppenheimer Downgrades PLx Pharma to Perform
Oppenheimer analyst Leland Gershell downgrades PLx Pharma (NASDAQ:PLXP) from Outperform to Perform.
Related Posts
6 Analysts Have This to Say About Zeta Global Holdings
Zeta Global Holdings (NYSE:ZETA) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent…
HC Wainwright & Co. Reiterates Buy on ADMA Biologics, Maintains $4.5 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates ADMA Biologics (NASDAQ:ADMA) with a Buy and maintains $4.5 price target.
Credit Suisse Maintains Outperform on Hanesbrands, Lowers Price Target to $13
Credit Suisse analyst Michael Binetti maintains Hanesbrands (NYSE:HBI) with a Outperform and lowers the price target from $15 to $13.